Changwei Ji

1.8k total citations
61 papers, 1.4k citations indexed

About

Changwei Ji is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Changwei Ji has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 32 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Changwei Ji's work include Renal cell carcinoma treatment (28 papers), Renal and related cancers (20 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Changwei Ji is often cited by papers focused on Renal cell carcinoma treatment (28 papers), Renal and related cancers (20 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Changwei Ji collaborates with scholars based in China, United States and Italy. Changwei Ji's co-authors include Hongqian Guo, Jillian Frieder, Zeyu Xiao, Omid C. Farokhzad, Eric M. Pridgen, Jinjun Shi, Jun Wu, Xiaozhi Zhao, Xiaogong Li and Guang‐Xiang Liu and has published in prestigious journals such as Angewandte Chemie International Edition, ACS Nano and Small.

In The Last Decade

Changwei Ji

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changwei Ji China 20 626 525 491 248 200 61 1.4k
Naishun Liao China 25 473 0.8× 656 1.2× 197 0.4× 214 0.9× 133 0.7× 53 1.4k
In-Hoo Kim South Korea 20 814 1.3× 618 1.2× 264 0.5× 211 0.9× 79 0.4× 47 1.7k
Wenhao Wang China 17 410 0.7× 421 0.8× 164 0.3× 153 0.6× 120 0.6× 73 1.2k
Tingsheng Lin China 18 281 0.4× 454 0.9× 212 0.4× 174 0.7× 188 0.9× 26 1.0k
Han Zhao China 21 427 0.7× 281 0.5× 197 0.4× 90 0.4× 126 0.6× 80 1.4k
Chaoyang Wu China 20 683 1.1× 283 0.5× 191 0.4× 134 0.5× 141 0.7× 52 1.4k
Ruizhong Zhang China 26 744 1.2× 335 0.6× 244 0.5× 94 0.4× 427 2.1× 70 2.3k
Wei‐Tso Chia Taiwan 20 432 0.7× 1.1k 2.2× 172 0.4× 470 1.9× 375 1.9× 45 2.0k
Fred Reynolds United States 17 534 0.9× 400 0.8× 113 0.2× 380 1.5× 101 0.5× 22 1.3k
Hongcheng Shi China 16 226 0.4× 405 0.8× 155 0.3× 302 1.2× 111 0.6× 65 1.0k

Countries citing papers authored by Changwei Ji

Since Specialization
Citations

This map shows the geographic impact of Changwei Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwei Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwei Ji more than expected).

Fields of papers citing papers by Changwei Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changwei Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwei Ji. The network helps show where Changwei Ji may publish in the future.

Co-authorship network of co-authors of Changwei Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Changwei Ji. A scholar is included among the top collaborators of Changwei Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changwei Ji. Changwei Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Changwei, et al.. (2024). Discovery of a highly potent, N-terminal domain-targeting degrader of AR-FL/AR-V7 for the treatment of prostate cancer. European Journal of Medicinal Chemistry. 282. 117079–117079. 1 indexed citations
2.
Zhang, Jun, et al.. (2023). Combination of robot-assisted laparoscopy and ureteroscopy for the management of complex ureteral strictures. BMC Urology. 23(1). 161–161. 2 indexed citations
7.
Zhang, Chengwei, Xiaozhi Zhao, Suhan Guo, et al.. (2018). Perioperative outcomes of zero ischemia radiofrequency ablation-assisted tumor enucleation for renal cell carcinoma: results of 182 patients. BMC Urology. 18(1). 41–41. 3 indexed citations
8.
Gao, Shuhong, et al.. (2017). Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma. Molecular Medicine Reports. 16(6). 8371–8379. 5 indexed citations
9.
Lu, Qun, Changwei Ji, Xiaozhi Zhao, et al.. (2017). Histopathologic analysis of tumor bed and peritumoral pseudocapsule after in vitro tumor enucleation on radical nephrectomy specimen for clinical T1b renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 35(10). 603.e15–603.e20. 13 indexed citations
10.
Zhang, Shengjie, et al.. (2016). Prognostic significance of modified Gleason scoring system after radical prostatectomy. Zhonghua miniao waike zazhi. 37(5). 344–348. 1 indexed citations
11.
Ji, Changwei, Yang Yang, Xiaozhi Zhao, et al.. (2016). Laparoscopic Partial Nephrectomy for Peripelvic Cystic Renal Cell Carcinoma: A Single-Center Experience. Urologia Internationalis. 97(2). 153–157. 3 indexed citations
12.
Yu, Bo, et al.. (2012). Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis. Molecular Biology Reports. 40(1). 617–623. 26 indexed citations
13.
Ji, Changwei, Weidong Gan, Hongqian Guo, et al.. (2012). A prospective trial on ureteral stenting combined with secondary ureteroscopy after an initial failed procedure. Urological Research. 40(5). 593–598. 20 indexed citations
14.
Ji, Changwei, Zhao Liu, Huimei Chen, Hongqian Guo, & Changjian Liu. (2012). An association between hOGG1Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis. BMC Cancer. 12(1). 335–335. 10 indexed citations
15.
Ji, Changwei, Xiaogong Li, Shiwei Zhang, et al.. (2011). Laparoscopic Radiofrequency Ablation of Renal Tumors: 32-Month Mean Follow-up Results of 106 Patients. Urology. 77(4). 798–802. 31 indexed citations
16.
Mao, Xiao‐Yuan, Changwei Ji, Chunyan Sun, et al.. (2011). Topiramate attenuates cerebral ischemia/reperfusion injury in gerbils via activating GABAergic signaling and inhibiting astrogliosis. Neurochemistry International. 60(1). 39–46. 28 indexed citations
17.
Zhao, Xiaozhi, Wei Wang, Shiwei Zhang, et al.. (2011). Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdominal Radiology. 37(5). 885–891. 38 indexed citations
18.
Lian, Huibo, Hongqian Guo, Weidong Gan, et al.. (2011). Cryosurgery as primary treatment for localized prostate cancer. International Urology and Nephrology. 43(4). 1089–1094. 13 indexed citations
19.
Lian, Huibo, Hongqian Guo, Weidong Gan, et al.. (2009). Comparison of clinical efficacy in the treatment of renal cell carcinoma: laparoscopic cool-tip radiofrequency ablation vs partial nephrectomy. Zhonghua miniao waike zazhi. 30(11). 731–734. 1 indexed citations
20.
Guo, Hongqian, Weidong Gan, Rong Yang, et al.. (2009). UP-1.057: Laparoscopic Cool-tip Radiofrequency Ablation in Renal Angiomyolipoma. Urology. 74(4). S188–S188. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026